Search research articles
Contact Us
Filters
Showing results (71-80 of 83) with videos related to
Page
of 9
Sort By:
The New England Journal of Medicine
|
October 3, 2019
Isoniazid Preventive Therapy in HIV-Infected Pregnant and Postpartum Women
Amita Gupta, Grace Montepiedra, Lisa Aaron, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 13, 2026
Hypertension in a randomized trial of dolutegravir- versus efavirenz-based antiretroviral therapy in pregnant and postpartum women with HIV
Risa Hoffman, Sean Brummel, Mauricio Pinilla, et al.
Cell Reports
|
July 20, 2022
Immune correlates of HIV-1 reservoir cell decline in early-treated infants
Ciputra Adijaya Hartana, Pilar Garcia-Broncano, Yelizaveta Rassadkina, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 15, 2015
Toward Earlier Inclusion of Pregnant and Postpartum Women in Tuberculosis Drug Trials: Consensus Statements From an International Expert Panel
Amita Gupta, Jyoti S Mathad, Susan M Abdel-Rahman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 5, 2024
Weight Changes and Adverse Pregnancy Outcomes With Dolutegravir- and Tenofovir Alafenamide Fumarate-Containing Antiretroviral Treatment Regimens During Pregnancy and Postpartum
Risa M Hoffman, Sean Brummel, Lauren Ziemba, et al.
The Lancet. HIV
|
May 11, 2023
Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trial
Lameck Chinula, Lauren Ziemba, Sean Brummel, et al.
The Journal of Infectious Diseases
|
June 5, 2024
Pharmacokinetics and Safety of Remdesivir in Pregnant and Nonpregnant Women With COVID-19: Results From IMPAACT 2032
Kristina M Brooks, Kristin Baltrusaitis, Diana F Clarke, et al.
The Lancet. Infectious Diseases
|
May 11, 2015
Towards early inclusion of children in tuberculosis drugs trials: a consensus statement
Sharon Nachman, Amina Ahmed, Farhana Amanullah, et al.
Science Translational Medicine
|
July 5, 2023
Broadly neutralizing antibody treatment maintained HIV suppression in children with favorable reservoir characteristics in Botswana
Roger L Shapiro, Gbolahan Ajibola, Kenneth Maswabi, et al.
The Journal of Infectious Diseases
|
March 27, 2012
Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panel
Stephen M Graham, Tahmeed Ahmed, Farhana Amanullah, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 83) with videos related to
Sort By:
Page
of 9
The New England Journal of Medicine
|
October 3, 2019
Isoniazid Preventive Therapy in HIV-Infected Pregnant and Postpartum Women
Amita Gupta, Grace Montepiedra, Lisa Aaron, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 13, 2026
Hypertension in a randomized trial of dolutegravir- versus efavirenz-based antiretroviral therapy in pregnant and postpartum women with HIV
Risa Hoffman, Sean Brummel, Mauricio Pinilla, et al.
Cell Reports
|
July 20, 2022
Immune correlates of HIV-1 reservoir cell decline in early-treated infants
Ciputra Adijaya Hartana, Pilar Garcia-Broncano, Yelizaveta Rassadkina, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 15, 2015
Toward Earlier Inclusion of Pregnant and Postpartum Women in Tuberculosis Drug Trials: Consensus Statements From an International Expert Panel
Amita Gupta, Jyoti S Mathad, Susan M Abdel-Rahman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 5, 2024
Weight Changes and Adverse Pregnancy Outcomes With Dolutegravir- and Tenofovir Alafenamide Fumarate-Containing Antiretroviral Treatment Regimens During Pregnancy and Postpartum
Risa M Hoffman, Sean Brummel, Lauren Ziemba, et al.
The Lancet. HIV
|
May 11, 2023
Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trial
Lameck Chinula, Lauren Ziemba, Sean Brummel, et al.
The Journal of Infectious Diseases
|
June 5, 2024
Pharmacokinetics and Safety of Remdesivir in Pregnant and Nonpregnant Women With COVID-19: Results From IMPAACT 2032
Kristina M Brooks, Kristin Baltrusaitis, Diana F Clarke, et al.
The Lancet. Infectious Diseases
|
May 11, 2015
Towards early inclusion of children in tuberculosis drugs trials: a consensus statement
Sharon Nachman, Amina Ahmed, Farhana Amanullah, et al.
Science Translational Medicine
|
July 5, 2023
Broadly neutralizing antibody treatment maintained HIV suppression in children with favorable reservoir characteristics in Botswana
Roger L Shapiro, Gbolahan Ajibola, Kenneth Maswabi, et al.
The Journal of Infectious Diseases
|
March 27, 2012
Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panel
Stephen M Graham, Tahmeed Ahmed, Farhana Amanullah, et al.
Page
of 9